In this final episode, Roger Barker, MD, PhD, and Claire Henchcliffe, MD, DPhil, discuss why neurologists should stay informed on stem cell medicine and the broader implications of regenerative therapies across neurology.
Roger A. Barker, MD, PhD
Advertisement
Articles by Roger A. Barker, MD, PhD
Neurologists Roger Barker, MD, PhD, and Claire Henchcliffe, MD, DPhil, discuss how stem cell therapies may differ from existing Parkinson disease treatments and the potential benefits of dopamine cell replacement.
Roger Barker, MD, PhD, and Claire Henchcliffe, MD, DPhil, examine the expanding clinical trial landscape for stem cell therapies in Parkinson disease and the programs leading development efforts.
From patient questions to clinical trial referrals, this episode highlights practical strategies for counseling individuals interested in stem cell-based therapies for Parkinson disease.
Neurologists Roger Barker, MBBS, MRCP, PhD, FMedSci, and Claire Henchcliffe, MD, DPhil, discuss the development, goals, and educational value of ISSCR's new stem cell medicine course for Parkinson disease.
Advertisement
Latest Updated Articles
A Call for Greater Education in Stem Cell TherapiesJune 6th 2026
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Differentiating Pathologic Features of Alzheimer Disease and Lewy Body Dementia: Charbel Moussa, MBBS, PhD
2
Improving Recognition and Treatment of Hyperkinetic Movement Disorders: Zoltan Mari, MD
3
Donanemab Shows Durable Amyloid Clearance and Consistent Safety in Early-Start Patients
4
Current and Emerging Strategies for Managing Huntington Disease Symptoms: Karen Anderson, MD
5